Omgene: R&D-based biopharmaceutical company with GMP facilities, focused on innovation and high-quality, affordable medicines.
01 3Omgene Life Sciences Pvt. Ltd
02 3Dr. Reddy's Laboratories
03 1Amryt Pharma
04 2Ascent Innovative Medicines
05 5Avet Pharmaceuticals
06 5Bioindustria L.I.M. Spa
07 3Biological E
08 1CHIESI USA INC
09 2Camurus
10 3Central Procurement & Supplies Unit
11 6Chemi SpA
12 2Cherubino Limited
13 1EJ Busuttil Ltd
14 2Farmak JSC
15 2Flagship Biotech International Pvt. Ltd
16 3Fresenius Kabi AB Brunna
17 5Fresenius Kabi USA
18 4GLAND PHARMA LIMITED
19 4GP Pharm
20 12Generic Health
21 1Hainan Shuangcheng Pharmaceuticals
22 4Hospira, Inc.
23 7Italfarmaco S.p.A
24 3LIFEPHARMA SpA
25 4Labatec Pharm
26 3Lifepharma
27 5Meitheal Pharmaceuticals
28 3Mepha Pharma
29 2Montage Laboratories
30 4Naprod Life Sciences
31 58Novartis Pharmaceuticals Corporation
32 6Novartis South Africa (Pty) Ltd
33 1ORIFARM GROUP AS
34 4Omega Laboratories Limited
35 2Pfizer Inc
36 3Pluviaendo
37 3Ratiopharm Espana Sa
38 5Sagent Pharmaceuticals
39 33Sun Pharmaceutical Industries Limited
40 12Teva Pharma Australia
41 17Teva Pharmaceutical Industries
42 1Varian Pharmed
43 6Viatris
44 5West-ward Pharmaceutical Corp
45 5Wockhardt
01 1Ampoule
02 1CAPSULE, DELAYED RELEASE;ORAL
03 1Enteric-Coated Capsules
04 2INF
05 6INJ
06 62INJECTABLE;INJECTION
07 3Injectable
08 3Injectable And Infusion Solution
09 3Injectable And Perfusion Solution
10 12Injectable Solution
11 3Injectable Suspension
12 5Injection
13 7Injection Solution
14 1KIT
15 2Liquid Injection
16 4Lyophilised Injection
17 1Octreotide 0.05Mg 10 Units Parenteral Use
18 1Octreotide 0.1Mg 10 Units Parenteral Use
19 1Octreotide 0.5Mg 10 Units Parenteral Use
20 1Octreotide 0.5Mg 3 Units' Parenteral Use
21 5Octreotide 100Mcg 5 Units Parenteral Use
22 1Octreotide 10Mg 1 Unit Parenteral Use
23 4Octreotide 1Mg 1 Unit Parenteral Use
24 1Octreotide 20Mg 1 Unit Parenteral Use
25 1Octreotide 30Mg 1 Unit Parenteral Use
26 4Octreotide 500Mcg 5 Units Parenteral Use
27 5Octreotide 50Mcg 5 Units Parenteral Use
28 5POWDER FOR SUSPENSION, SUSTAINED-RELEASE
29 3Powder And Solvent For Extended-Release Injectable Suspension
30 7Powder And Solvent For Injectable Suspension
31 6Powder And Solvent For Prolonged-Release Injectable Suspension
32 6Powder And Solvent For Prolonged-Release Suspension For Injection
33 9Powder For Injection
34 2Pre-Filled Syringe
35 1Prolonged Release Solution For Injection
36 1Prolonged-Release Injection Solution
37 5SOLUTION
38 1SOLUTION;SUBCUTANEOUS
39 1Solution
40 14Solution For Injection
41 4Solution For Injection And Infusion
42 5Solution For Injection In Pre-Filled
43 1Solution For Injection In Pre-Filled Syringe
44 1Solution For Injection Or Concentrate For Solution For Infusion
45 1Solution For Injection/Infusion
46 1Solution for Injection
47 3Vial
48 18injection
49 30Blank
01 13Allowed
02 10Authorised
03 12Authorized
04 10Cancelled
05 18DISCN
06 4Generic
07 6Originator
08 34Prescription
09 46RX
10 4Withdrawn
11 109Blank
01 1BYNFEZIA PEN
02 4Longastatina
03 3Longastatina Lar
04 1MYCAPSSA
05 1Mycapssa
06 39OCTREOTIDE ACETATE
07 12OCTREOTIDE ACETATE (PRESERVATIVE FREE)
08 4OCTREOTIDE ACETATE OMEGA
09 3OCTREOTIDE ACETATE PRESERVATIVE FREE
10 1OCTREOTIDE BIOINDUSTRY LIM
11 3OCTREOTIDE FOR INJECTABLE SUSPENSION
12 4OCTREOTIDE SUN
13 1OCTREOTIDE TEVA 20
14 1OCTREOTIDE TEVA 30
15 2Octra
16 2Octreo-Ratiopharm
17 3Octreoanne
18 4Octreotida Gp-Pharm
19 2Octreotida Hospira
20 3Octreotida Ratiopharm
21 4Octreotida Sun
22 3Octreotida Teva
23 20Octreotide
24 6Octreotide (SUN)
25 3Octreotide Acetate
26 6Octreotide Acetate Omega (Canada)
27 2Octreotide Bendalis
28 12Octreotide Depot
29 6Octreotide GH
30 4Octreotide Labatec
31 1Octreotide Sun
32 3Octreotide Teva
33 4Octreotide "Sun"
34 3Octreotide-Mepha LA
35 2Oczyesa
36 2Olatuton
37 6SANDOSTATIN
38 6SANDOSTATIN LAR
39 3SIROCTID
40 13Sandostatin
41 1Sandostatin 1Mg/5Ml Injection
42 2Sandostatin 0.05
43 2Sandostatin 0.1
44 2Sandostatin 0.5
45 12Sandostatin LAR
46 3Sandostatin LAR Fertigspritzen
47 12Sandostatin Lar
48 1Sandostatin Lar 10Mg
49 1Sandostatin Lar 20Mg
50 1Sandostatin Lar 30Mg
51 2Sandostatin®
52 3Siroctid
53 3TREOJECT
54 3Treoject
55 15Blank
01 48Australia
02 11Canada
03 15Denmark
04 8Estonia
05 19India
06 1Iran
07 36Italy
08 14Malta
09 3Moldova
10 8South Africa
11 22Spain
12 13Switzerland
13 3Turkey
14 64USA
15 1Ukraine
Omgene: R&D-based biopharmaceutical company with GMP facilities, focused on innovation and high-quality, affordable medicines.
Regulatory Info :
Registration Country : India
Brand Name : Octreotide Acetate
Dosage Form : Injectable Suspension
Dosage Strength : 10MG
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : India
DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.
Regulatory Info :
Registration Country : India
Brand Name : Octreotide
Dosage Form : Injectable
Dosage Strength : 10 mg
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : India
Omgene: R&D-based biopharmaceutical company with GMP facilities, focused on innovation and high-quality, affordable medicines.
Regulatory Info :
Registration Country : India
Brand Name : Octreotide Acetate
Dosage Form : Injectable Suspension
Dosage Strength : 20MG
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : India
Omgene: R&D-based biopharmaceutical company with GMP facilities, focused on innovation and high-quality, affordable medicines.
Regulatory Info :
Registration Country : India
Brand Name : Octreotide Acetate
Dosage Form : Injectable Suspension
Dosage Strength : 30MG
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : India
DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.
Regulatory Info :
Registration Country : India
Brand Name : Octreotide
Dosage Form : Injectable
Dosage Strength : 20 mg
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : India
DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.
Regulatory Info :
Registration Country : India
Brand Name : Octreotide
Dosage Form : Injectable
Dosage Strength : 30 mg
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : India
Regulatory Info : Prescription
Registration Country : Denmark
Brand Name : Mycapssa
Dosage Form : Enteric-Coated Capsules
Dosage Strength : 20mg
Packaging :
Approval Date : 02-12-2022
Application Number : 28106649621
Regulatory Info : Prescription
Registration Country : Denmark
Regulatory Info : RX
Registration Country : USA
Brand Name : SANDOSTATIN
Dosage Form : INJECTABLE;INJECTION
Dosage Strength : EQ 0.05MG BASE/ML
Packaging :
Approval Date : 1988-10-21
Application Number : 19667
Regulatory Info : RX
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
Brand Name : SANDOSTATIN
Dosage Form : INJECTABLE;INJECTION
Dosage Strength : EQ 0.1MG BASE/ML
Packaging :
Approval Date : 1988-10-21
Application Number : 19667
Regulatory Info : RX
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
Brand Name : SANDOSTATIN
Dosage Form : INJECTABLE;INJECTION
Dosage Strength : EQ 0.5MG BASE/ML
Packaging :
Approval Date : 1988-10-21
Application Number : 19667
Regulatory Info : RX
Registration Country : USA
Regulatory Info : DISCN
Registration Country : USA
Brand Name : SANDOSTATIN
Dosage Form : INJECTABLE;INJECTION
Dosage Strength : EQ 0.2MG BASE/ML **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
Packaging :
Approval Date : 1991-06-12
Application Number : 19667
Regulatory Info : DISCN
Registration Country : USA
Regulatory Info : DISCN
Registration Country : USA
Brand Name : SANDOSTATIN
Dosage Form : INJECTABLE;INJECTION
Dosage Strength : EQ 1MG BASE/ML **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
Packaging :
Approval Date : 1991-06-12
Application Number : 19667
Regulatory Info : DISCN
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
Brand Name : SANDOSTATIN LAR
Dosage Form : INJECTABLE;INJECTION
Dosage Strength : EQ 10MG BASE/VIAL
Packaging :
Approval Date : 1998-11-25
Application Number : 21008
Regulatory Info : RX
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
Brand Name : SANDOSTATIN LAR
Dosage Form : INJECTABLE;INJECTION
Dosage Strength : EQ 20MG BASE/VIAL
Packaging :
Approval Date : 1998-11-25
Application Number : 21008
Regulatory Info : RX
Registration Country : USA
Regulatory Info : Prescription
Registration Country : Denmark
Brand Name : Sandostatin Lar
Dosage Form : Powder For Injection
Dosage Strength : 20mg
Packaging :
Approval Date : 16-07-1996
Application Number : 28101706094
Regulatory Info : Prescription
Registration Country : Denmark
Regulatory Info : Prescription
Registration Country : Denmark
Brand Name : Sandostatin Lar
Dosage Form : Powder For Injection
Dosage Strength : 30mg
Packaging :
Approval Date : 16-07-1996
Application Number : 28101706194
Regulatory Info : Prescription
Registration Country : Denmark
Regulatory Info : Prescription
Registration Country : Denmark
Brand Name : Sandostatin
Dosage Form : Injection Solution
Dosage Strength : 100mcg/ml
Packaging :
Approval Date : 16-05-1988
Application Number : 28101298887
Regulatory Info : Prescription
Registration Country : Denmark
Regulatory Info : Prescription
Registration Country : Denmark
Brand Name : Octreotide \"Sun\"
Dosage Form : Injection Solution
Dosage Strength : 1mg/5ml
Packaging :
Approval Date : 22-06-2011
Application Number : 28104808910
Regulatory Info : Prescription
Registration Country : Denmark
Regulatory Info : Prescription
Registration Country : Denmark
Brand Name : Octreoanne
Dosage Form : Powder And Solvent For Prolonged-Release Suspension For Injection
Dosage Strength : 20mg
Packaging :
Approval Date : 10-05-2019
Application Number : 28106033617
Regulatory Info : Prescription
Registration Country : Denmark
Regulatory Info : Prescription
Registration Country : Denmark
Brand Name : Octreoanne
Dosage Form : Powder And Solvent For Prolonged-Release Suspension For Injection
Dosage Strength : 30mg
Packaging :
Approval Date : 10-05-2019
Application Number : 28106033717
Regulatory Info : Prescription
Registration Country : Denmark
